Skip to main content Skip to main content

For questions about financial assistance, call 1-844-DUPIXENT, option 1 or
click to learn more  

NOW APPROVED:

For the treatment of Allergic Fungal
Rhinosinusitis (AFRS) in patients 6+ Years who have
had surgery on their nose or sinuses in the past

learn more

As the first and only FDA-approved biologic for
Chronic Spontaneous Urticaria (CSU) patients as
young as 2 years old with hives not controlled by
H1 antihistamines

  DUPIXENT is not used to treat any other forms of hives (urticaria)

learn more
US.DUP.26.02.0296

EXPLORE RESULTS WITH DUPIXENT

APPROVED FOR 9 INDICATIONS AND WITH MORE THAN 1 MILLION PATIENTS ON THERAPY WORLDWIDE*

Choose your condition

Uncontrolled Moderate-to-Severe

Eczema (Atopic Dermatitis
or AD)

Ages 6+ Months

Add-on Maintenance Treatment for Uncontrolled
Moderate-to-Severe Eosinophilic or Oral
Steroid Dependent

Asthma

Ages 6+ Years

  DUPIXENT is not used to relieve sudden breathing
problems and will not replace an inhaled rescue medicine

Add-on Maintenance Treatment for Inadequately Controlled

Chronic Obstructive Pulmonary
Disease (COPD)

with high blood eosinophils
Ages 18+ Years

  DUPIXENT is not used to relieve sudden breathing
problems and will not replace an inhaled rescue medicine

Add-on Maintenance Treatment for Uncontrolled

Chronic Rhinosinusitis with
Nasal Polyps (CRSwNP)

Ages 12+ Years
NOW APPROVED

Allergic Fungal
Rhinosinusitis (AFRS)

Ages 6+ Years who have had surgery on their
nose or sinuses in the past

Eosinophilic Esophagitis (EoE)

Ages 1+ Years, who weigh at least 33 lb (15 kg)
NOW APPROVED IN
2+ YEARS

Chronic Spontaneous
Urticaria (CSU)

with hives not controlled by H1 antihistamines Ages 2+ Years

  DUPIXENT is not used to treat any other forms of
hives (urticaria)

Prurigo Nodularis (PN)

Ages 18+ Years

Bullous Pemphigoid (BP)

Ages 18+ Years

*The worldwide patient number is largely represented by 10 countries and includes patients on therapy for select conditions approved for use in the US. Data through April 2026.

Dupixent MyWay® Copay Card

AS LITTLE AS $0† COPAY
MAY BE AVAILABLE

With the DUPIXENT MyWay® Copay Card, eligible patients with commercial health insurance may pay as little as $0† in copay per fill of DUPIXENT.

CHECK COPAY CARD
ELIGIBILITY
†Subject to the program maximum per patient per calendar year. Approval is not guaranteed. THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs, including any state pharmaceutical assistance programs. This program is not valid where prohibited by law, taxed, or restricted. DUPIXENT MyWay reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Any savings provided by the program may vary depending on patients' out-of-pocket costs. The program is intended to help patients afford DUPIXENT. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms. Additional terms and conditions apply.

Sign up for news about DUPIXENT

Receive emails to help support your journey.

  • Treatment tips and guidance – practical support for your care plan
  • Educational resources – articles, videos, and updates about your condition and treatment
  • Offers and savings – notifications about eligibility, financial assistance, and other patient support
  • Real stories – insights from other patients and caregivers sharing personal experiences